FAQ Library

Beth Faiman, a nurse practitioner, discusses factors to consider in determining therapy for patients with renal insufficiency and diagnosing myeloma.
FAQ Library published on August 20, 2009 in Comorbidities/SEs
Dr. Anderson discusses whether erythropoietin stimulating agents (ESAs) have a place in managing myeloma patients with anemia.
Tiffany Richards discusses key points to remember when preparing myeloma patients for transplant.
FAQ Library published on July 22, 2009 in Response Assessment
Dr. Mohrbacher discusses what quality parameters are currently important as clinical endpoints in trials to predict outcomes for MM treatments.
FAQ Library published on June 12, 2009 in Comorbidities/SEs
Dr. Anderson discusses approaches for the prevention of infections in multiple myeloma patients.
FAQ Library published on June 12, 2009 in Comorbidities/SEs
Dr. Berenson discusses strategies for the prevention of bone loss and boney complications in myeloma patients.
FAQ Library published on May 29, 2009 in Comorbidities/SEs
Dr. Mohrbacher discusses what to do with MM patients in renal failure and what can be done to reverse renal failure.
FAQ Library published on March 18, 2009 in Comorbidities/SEs, Nurses & Pharmacists, PN
Beth Faiman defines peripheral neuropathy and its implication on multiple myeloma patients.
FAQ Library published on March 18, 2009 in Comorbidities/SEs, Bone Disease
Dr. Anderson provides quick tips on bisphosphonate use in multiple myeloma.
FAQ Library published on February 18, 2009 in Comorbidities/SEs
Dr. Mohrbacher discusses the appropriate use of IVIGs in patients with multiple myeloma.
Page 13 of 14
Results 121 - 130 of 133